Cargando…
Potential hepatoprotective effects of flavonoids contained in propolis from South Sulawesi against chemotherapy agents
The use of doxorubicin and epirubicin as chemotherapy agent causes side effects such as liver damage due to oxidative stress by reactive oxygen species (ROS) that cause increased of ALT and AST level as liver parameter. One source of natural antioxidants as ROS neutralizer comes from flavonoid that...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459154/ https://www.ncbi.nlm.nih.gov/pubmed/34588856 http://dx.doi.org/10.1016/j.sjbs.2021.08.022 |
_version_ | 1784571460240539648 |
---|---|
author | Sahlan, Muhamad Rizka Alia Hapsari, Nur Diah Pratami, Kartika Cahya Khayrani, Apriliana Lischer, Kenny Alhazmi, Alaa Mohammedsaleh, Zuhair M. Shater, Abdullah F. Saleh, Fayez M. Alsanie, Walaa F. Sayed, Samy Gaber, Ahmed |
author_facet | Sahlan, Muhamad Rizka Alia Hapsari, Nur Diah Pratami, Kartika Cahya Khayrani, Apriliana Lischer, Kenny Alhazmi, Alaa Mohammedsaleh, Zuhair M. Shater, Abdullah F. Saleh, Fayez M. Alsanie, Walaa F. Sayed, Samy Gaber, Ahmed |
author_sort | Sahlan, Muhamad |
collection | PubMed |
description | The use of doxorubicin and epirubicin as chemotherapy agent causes side effects such as liver damage due to oxidative stress by reactive oxygen species (ROS) that cause increased of ALT and AST level as liver parameter. One source of natural antioxidants as ROS neutralizer comes from flavonoid that contain in propolis. Most researchers claim that flavonoid can be used to protect the liver. The aim of this study was to test the hepatoprotective effect of flavonoid in propolis from South Sulawesi against doxorubicin and epirubicin. The experiment included male Sprague dawley rats divided into nine groups. The rats received the microcapsule propolis or the quercetin orally for 15 days. The hepatotoxicity was promoted by injection epirubicin and doxorubicin (i.v.) with a cumulative dose of 9 mg/kg. In this study, total polyphenol and flavonoid tests of propolis have been carried out, there were 1.1% polyphenols and 2.7% flavonoids, the antioxidant activity tests showed IC50 value of 9849 ppm and LCMS/MS tests supported the presence of phenolic compounds in propolis from South Sulawesi. Liver parameter was measured and the results showed that the propolis 200 mg/kg group produced the lowest ALT and had potential protective effect against doxorubicin and epirubicin-induced hepatotoxicity. |
format | Online Article Text |
id | pubmed-8459154 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-84591542021-09-28 Potential hepatoprotective effects of flavonoids contained in propolis from South Sulawesi against chemotherapy agents Sahlan, Muhamad Rizka Alia Hapsari, Nur Diah Pratami, Kartika Cahya Khayrani, Apriliana Lischer, Kenny Alhazmi, Alaa Mohammedsaleh, Zuhair M. Shater, Abdullah F. Saleh, Fayez M. Alsanie, Walaa F. Sayed, Samy Gaber, Ahmed Saudi J Biol Sci Original Article The use of doxorubicin and epirubicin as chemotherapy agent causes side effects such as liver damage due to oxidative stress by reactive oxygen species (ROS) that cause increased of ALT and AST level as liver parameter. One source of natural antioxidants as ROS neutralizer comes from flavonoid that contain in propolis. Most researchers claim that flavonoid can be used to protect the liver. The aim of this study was to test the hepatoprotective effect of flavonoid in propolis from South Sulawesi against doxorubicin and epirubicin. The experiment included male Sprague dawley rats divided into nine groups. The rats received the microcapsule propolis or the quercetin orally for 15 days. The hepatotoxicity was promoted by injection epirubicin and doxorubicin (i.v.) with a cumulative dose of 9 mg/kg. In this study, total polyphenol and flavonoid tests of propolis have been carried out, there were 1.1% polyphenols and 2.7% flavonoids, the antioxidant activity tests showed IC50 value of 9849 ppm and LCMS/MS tests supported the presence of phenolic compounds in propolis from South Sulawesi. Liver parameter was measured and the results showed that the propolis 200 mg/kg group produced the lowest ALT and had potential protective effect against doxorubicin and epirubicin-induced hepatotoxicity. Elsevier 2021-10 2021-08-13 /pmc/articles/PMC8459154/ /pubmed/34588856 http://dx.doi.org/10.1016/j.sjbs.2021.08.022 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Sahlan, Muhamad Rizka Alia Hapsari, Nur Diah Pratami, Kartika Cahya Khayrani, Apriliana Lischer, Kenny Alhazmi, Alaa Mohammedsaleh, Zuhair M. Shater, Abdullah F. Saleh, Fayez M. Alsanie, Walaa F. Sayed, Samy Gaber, Ahmed Potential hepatoprotective effects of flavonoids contained in propolis from South Sulawesi against chemotherapy agents |
title | Potential hepatoprotective effects of flavonoids contained in propolis from South Sulawesi against chemotherapy agents |
title_full | Potential hepatoprotective effects of flavonoids contained in propolis from South Sulawesi against chemotherapy agents |
title_fullStr | Potential hepatoprotective effects of flavonoids contained in propolis from South Sulawesi against chemotherapy agents |
title_full_unstemmed | Potential hepatoprotective effects of flavonoids contained in propolis from South Sulawesi against chemotherapy agents |
title_short | Potential hepatoprotective effects of flavonoids contained in propolis from South Sulawesi against chemotherapy agents |
title_sort | potential hepatoprotective effects of flavonoids contained in propolis from south sulawesi against chemotherapy agents |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459154/ https://www.ncbi.nlm.nih.gov/pubmed/34588856 http://dx.doi.org/10.1016/j.sjbs.2021.08.022 |
work_keys_str_mv | AT sahlanmuhamad potentialhepatoprotectiveeffectsofflavonoidscontainedinpropolisfromsouthsulawesiagainstchemotherapyagents AT rizkaaliahapsarinur potentialhepatoprotectiveeffectsofflavonoidscontainedinpropolisfromsouthsulawesiagainstchemotherapyagents AT diahpratamikartika potentialhepatoprotectiveeffectsofflavonoidscontainedinpropolisfromsouthsulawesiagainstchemotherapyagents AT cahyakhayraniapriliana potentialhepatoprotectiveeffectsofflavonoidscontainedinpropolisfromsouthsulawesiagainstchemotherapyagents AT lischerkenny potentialhepatoprotectiveeffectsofflavonoidscontainedinpropolisfromsouthsulawesiagainstchemotherapyagents AT alhazmialaa potentialhepatoprotectiveeffectsofflavonoidscontainedinpropolisfromsouthsulawesiagainstchemotherapyagents AT mohammedsalehzuhairm potentialhepatoprotectiveeffectsofflavonoidscontainedinpropolisfromsouthsulawesiagainstchemotherapyagents AT shaterabdullahf potentialhepatoprotectiveeffectsofflavonoidscontainedinpropolisfromsouthsulawesiagainstchemotherapyagents AT salehfayezm potentialhepatoprotectiveeffectsofflavonoidscontainedinpropolisfromsouthsulawesiagainstchemotherapyagents AT alsaniewalaaf potentialhepatoprotectiveeffectsofflavonoidscontainedinpropolisfromsouthsulawesiagainstchemotherapyagents AT sayedsamy potentialhepatoprotectiveeffectsofflavonoidscontainedinpropolisfromsouthsulawesiagainstchemotherapyagents AT gaberahmed potentialhepatoprotectiveeffectsofflavonoidscontainedinpropolisfromsouthsulawesiagainstchemotherapyagents |